Bertoia Monica L, Bertrand Kimberly A, Sawyer Sherilyn J, Rimm Eric B, Mukamal Kenneth J
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
PLoS One. 2015 Aug 27;10(8):e0136665. doi: 10.1371/journal.pone.0136665. eCollection 2015.
Most studies of microRNA (miRNA) and disease have examined tissue-specific expression in limited numbers of samples. The presence of circulating miRNAs in plasma samples provides the opportunity to examine prospective associations between miRNA expression and disease in initially healthy individuals. However, little data exist on the reproducibility of miRNAs in stored plasma.
We used Real-Time PCR to measure 61 pre-selected microRNA candidates in stored plasma. Coefficients of variation (CVs) were used to assess inter-assay reliability (n = 15) and within-person stability over one year (n = 80). Intraclass correlation coefficients (ICCs) and polychoric correlation coefficients were used to assess within-person stability and delayed processing reproducibility (whole blood stored at 4°C for 0, 24 and 48 hours; n = 12 samples).
Of 61 selected miRNAs, 23 were detected in at least 50% of samples and had average CVs below 20% for inter-assay reproducibility and 31 for delayed processing reproducibility. Ten miRNAs were detected in at least 50% of samples, had average CVs below 20% and had ICCs above 0.4 for within-person stability over 1-2 years, six of which satisfied criteria for both interassay reproducibility and short-term within-person stability (miR-17-5p, -191-5p, -26a-5p, -27b-3p, -320a, and -375) and two all three types of reproducibility (miR-27b-3p and -26a-5p). However, many miRNAs with acceptable average CVs had high maximum CVs, most had low expression levels, and several had low ICCs with delayed processing.
About a tenth of miRNAs plausibly related to chronic disease were reliably detected in stored samples of healthy adults.
大多数关于微小RNA(miRNA)与疾病的研究仅在有限数量的样本中检测了组织特异性表达。血浆样本中循环miRNA的存在为研究初始健康个体中miRNA表达与疾病之间的前瞻性关联提供了机会。然而,关于储存血浆中miRNA的可重复性的数据很少。
我们使用实时聚合酶链反应(Real-Time PCR)来测量储存血浆中预先选择的61种miRNA候选物。变异系数(CVs)用于评估批间可靠性(n = 15)和一年内个体内稳定性(n = 80)。组内相关系数(ICCs)和多相相关系数用于评估个体内稳定性和延迟处理可重复性(全血在4°C下储存0、24和48小时;n = 12个样本)。
在61种选定的miRNA中,23种在至少50%的样本中被检测到,批间可重复性的平均CVs低于20%,延迟处理可重复性的平均CVs低于31%。10种miRNA在至少50%的样本中被检测到,平均CVs低于20%,在1至2年的个体内稳定性方面ICCs高于0.4,其中6种同时满足批间可重复性和短期个体内稳定性标准(miR-17-5p、-191-5p、-26a-5p、-27b-3p、-320a和-375),2种满足所有三种可重复性类型(miR-27b-3p和-26a-5p)。然而,许多平均CVs可接受的miRNA最大CVs较高,大多数表达水平较低,还有几种在延迟处理时ICCs较低。
在健康成年人的储存样本中,约十分之一的可能与慢性病相关的miRNA能够被可靠检测到。